Creative Medical Technology Holdings (CELZ) EBIT Margin (2017 - 2025)
Creative Medical Technology Holdings' EBIT Margin was -64859.40% in Q4 2025, down 2001.60 percentage points from -62857.80% a year earlier.
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) EBIT Margin (2017 - 2025) Analysis & Trends
For FY2025, EBIT Margin at Creative Medical Technology Holdings came in at -102380.23%, down 50163.32 percentage points from FY2024.
- EBIT Margin shows a five-year change of -101702.52 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -52216.92% in FY2024 (+10228.99 pp), -62445.91% in FY2023 (-50883.41 pp), -11562.50% in FY2022 (-8000.32 pp) and -3562.17% in FY2021 (-2884.46 pp).
- The Q4 2025 figure marks the lowest quarterly EBIT Margin in data going back to Q4 2017.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2022 (a gain of 6479.05 percentage points); the worst was Q4 2022 (a drop of 31578.71 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.13 Bn | 1,100.72 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 634.87 Bn | 554.73 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 506.59 Bn | 479.70 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 357.59 Bn | 311.97 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 291.51 Bn | 255.50 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.00 Bn | 238.69 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 238.17 Bn | 193.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 195.18 Bn | 169.37 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.20 Bn | 117.84 Bn | 10.94 Bn | 28.37% |
| 10 | Creative Medical Technology Holdings | 1.04 Mn | -25.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -64,859.40% |
| Mar 31, 2025 | -55,349.27% |
| Dec 31, 2024 | -62,857.80% |
| Jun 30, 2024 | -20,316.33% |
| Dec 31, 2023 | -59,061.30% |
| Sep 30, 2023 | -25,719.75% |
| Dec 31, 2022 | -33,752.35% |
| Sep 30, 2022 | -1,855.31% |
| Mar 31, 2022 | -7,699.13% |
| Dec 31, 2021 | -2,173.64% |
| Sep 30, 2021 | -8,334.36% |
| Jun 30, 2021 | -5,158.42% |
| Dec 31, 2020 | -1,846.08% |
| Sep 30, 2020 | -314.90% |
| Jun 30, 2020 | -767.97% |
| Mar 31, 2020 | -795.81% |
| Sep 30, 2019 | -475.52% |
| Jun 30, 2019 | -447.17% |
| Mar 31, 2019 | -493.50% |
| Dec 31, 2018 | -556.15% |
API Access
Creative Medical Technology Holdings EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CELZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CELZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CELZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();